Streetbeat News

Revenues

OBDC

Blue Owl Capital (NYSE:OBDC) received mixed analyst ratings over the past quarter, with 3 somewhat bullish and 1 indifferent rating. The 12-month price targets show an average of $15.62, with a recent upward trend from the previous $15.00 average. Analysts from B. Riley Securities, RBC Capital, JMP Securities, and Raymond James have provided updates, with two maintaining and two raising their price targets. Blue Owl Capital, a specialty finance company, has seen a revenue decline of -19.83% over the past 3 months but maintains a high net margin of 91.81%. Its ROE and debt-to-equity ratio suggest some financial challenges.

Portfolio Pulse from Benzinga Insights

January 08, 2024 | 4:01 pm

CSCO

Cisco Systems (NASDAQ:CSCO) has received mixed analyst ratings over the last quarter, with a shift towards a more indifferent stance in the past 30 days. The average 12-month price target for Cisco is $52.33, with a high of $55.00 and a low of $50.00, marking an 8.59% decrease from the previous average. Recent actions by analysts include maintaining 'Hold' ratings and lowering price targets, reflecting changes in market dynamics and company performance. Cisco's financial performance is strong, with a market cap above industry average, revenue growth of 7.6%, a net margin of 24.8%, an ROE of 8.12%, an ROA of 3.63%, and a low debt-to-equity ratio of 0.17.

Portfolio Pulse from Benzinga Insights

January 08, 2024 | 4:00 pm

MET

MetLife (NYSE:MET) has been reviewed by 4 analysts in the last three months, with a mix of bullish and somewhat bullish ratings. The average 12-month price target is $77.0, down from the previous $79.0. Analysts from Goldman Sachs, Keefe, Bruyette & Woods, Barclays, and Morgan Stanley have provided updates, with price targets ranging from $71.00 to $80.00. MetLife's financials show challenges in revenue growth, net margin, ROE, and ROA, but a prudent debt management strategy.

Portfolio Pulse from Benzinga Insights

January 08, 2024 | 4:00 pm

TLYS

Tilly's, Inc (NYSE:TLYS) reported a 7.4% decline in holiday sales, with a 9.0% decrease in total comparable net sales. Physical store sales dropped by 12.3%, while e-commerce sales saw a slight increase of 1.6%. The company revised its Q4 FY23 EPS loss forecast to $(0.20) - $(0.24) from $(0.12) - $(0.20) and lowered its Q4 sales outlook to $169 million - $172 million from $172 million - $178 million. Tilly's stock price fell by 2.05% to $7.17.

Portfolio Pulse from Shivani Kumaresan

January 08, 2024 | 3:53 pm

EWCZ

European Wax Center, Inc (NASDAQ:EWCZ) has raised its FY23 revenue and system-wide sales guidance, with same-store sales growth outlook also increased. The company reaffirmed its FY23 adjusted net income and EBITDA outlook. CEO David Willis highlighted strong unit growth and a recurring revenue stream from core guests. EWCZ repurchased 1.7 million shares in Q4 2023. The company's full audited financial results will be released in early March 2024. EWCZ shares saw a 20% increase in price.

Portfolio Pulse from Shivani Kumaresan

January 08, 2024 | 3:38 pm

PTN

Palatin Technologies, Inc. provided a corporate update, highlighting its strategic priorities for 2024, including clinical development milestones. The company completed the sale of Vyleesi to Cosette Pharmaceuticals for up to $171 million, with $12 million upfront and up to $159 million in sales-based milestones. Palatin is focusing on melanocortin receptor system modulators, with Phase 3 data for Dry Eye Disease expected in early Q1 2024, Phase 2 data for Ulcerative Colitis in Q1 and Q2 2024, and Phase 2 studies for obesity and male sexual dysfunction starting in Q1 2024.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 3:34 pm

HUBC

HUB Cyber Security Ltd (HUBC) projects strong growth with over $100M in expected revenues by 2025, driven by existing and new contracts. Despite a temporary 18% revenue decline in H1 2023 due to Q1 mismanagement, the company has improved its Adjusted EBITDA and cash flow. With over $40M in new contracts and a focus on Confidential Computing and Data Fabric solutions, HUBC aims to lead the market. The company has a 93% gross retention rate and a robust balance sheet with $52.8M in assets as of June 30, 2023.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 3:30 pm

CUEN

Cuentas, Inc. CEO Arik Maimon released a shareholder letter highlighting the company's achievements in 2023, including strong shareholder support with over 62% approval in proxy votes, revenue growth, and successful real estate ventures. The company, serving the Hispanic market, offers integrated mobile, fintech, and real estate services, including Cuentas Mobile and Cuentas Money. The CEO emphasized the success of the Lakewood Village project and the upcoming Tampa project, with Tampa being a fast-growing real estate market. Maimon expressed confidence in the company's unique position and future growth.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 3:15 pm

CMC

Commercial Metals Co (NYSE:CMC) reported Q1 FY24 sales of $2.00 billion, surpassing consensus estimates of $1.89 billion. Despite a decrease in the average selling price for steel products and a drop in core EBITDA year-over-year, the company saw a slight increase in finished steel volumes and beat adjusted EPS estimates. CMC declared a quarterly dividend, repurchased shares, and expects robust construction activity to support demand. Shares rose by 7.27% to $51.72.

Portfolio Pulse from Lekha Gupta

January 08, 2024 | 3:12 pm

AXNX

BSX

Boston Scientific Corporation (NYSE:BSX) is set to acquire Axonics Inc (NASDAQ:AXNX) for $71 per share, totaling an enterprise value of $3.4 billion and an equity value of $3.7 billion. Axonics, which specializes in bladder disorder treatments, has reported a 34% revenue growth and expects $366 million in net revenue for 2023. The acquisition is expected to significantly benefit Boston Scientific's Urology business starting in 2024. The transaction has been unanimously approved by both companies' boards and is expected to close in the first half of 2024. Following the news, AXNX shares rose by 20.20%, while BSX shares saw a slight decline of 0.62%.

Portfolio Pulse from Vandana Singh

January 08, 2024 | 3:11 pm